Susan Collins actually said...
We looked at Turing, we looked at Valeant, and what we found was a pattern of certain, what I call, hedge fund pharma companies buying the rights to a drug and then, overnight, increasing the cost by as much as literally 5,000 percent in the case of Daraprim.
Context
Senator Collins highlights drastic price hikes by pharmaceutical companies after acquiring drug rights.
10/16/2017